Cargando…

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

BACKGROUND: The Swedish National Cervical Screening Registry collects and evaluates comprehensive, nationwide health data to optimise organised cervical cancer prevention. Since all cervical cancer specimens are saved in biobanks, population-based data from the specimens should be available for anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lagheden, Camilla, Eklund, Carina, Lamin, Helena, Kleppe, Sara Nordqvist, Lei, Jiayao, Elfström, K. Miriam, Sundström, Karin, Andrae, Bengt, Sparén, Pär, Dillner, Joakim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959883/ https://www.ncbi.nlm.nih.gov/pubmed/29559733 http://dx.doi.org/10.1038/s41416-018-0053-6

Ejemplares similares

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study
por: Andrae, Bengt, et al.
Publicado: (2019)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
por: Wang, Jiangrong, et al.
Publicado: (2017)

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study
por: Wang, Jiangrong, et al.
Publicado: (2016)

Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study
por: Arroyo-Mühr, Laila Sara, et al.
Publicado: (2018)

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60
por: Lamin, Helena, et al.
Publicado: (2017)

De novo sequence assembly requires bioinformatic checking of chimeric sequences
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

HPV transcription in skin tumors
por: Hultin, Emilie, et al.
Publicado: (2019)

Cervical cancer screening in Sweden 2014-2016
por: Hortlund, Maria, et al.
Publicado: (2018)

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
por: Elfström, K Miriam, et al.
Publicado: (2014)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study
por: Herweijer, Eva, et al.
Publicado: (2015)

Antibodies to SARS-CoV-2 and risk of past or future sick leave
por: Dillner, Joakim, et al.
Publicado: (2021)

Deep sequencing extends the diversity of human papillomaviruses in human skin
por: Bzhalava, Davit, et al.
Publicado: (2014)

Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling
por: Lei, Jiayao, et al.
Publicado: (2022)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil
por: Miyaji, Karina Takesaki, et al.
Publicado: (2022)

Expressed Prostate Secretions in the Study of Human Papillomavirus Epidemiology in the Male
por: Smelov, Vitaly, et al.
Publicado: (2013)

Screening and cervical cancer cure: population based cohort study
por: Andrae, Bengt, et al.
Publicado: (2012)

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
por: Leval, Amy, et al.
Publicado: (2013)

Opportunistic HPV vaccination at age 16–23 and cervical screening attendance in Sweden: a national register-based cohort study
por: Kreusch, Teresa, et al.
Publicado: (2018)

High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012–2019
por: Wang, Jiangrong, et al.
Publicado: (2023)

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
por: Lehtinen, Matti, et al.
Publicado: (2021)

A pilot study of risk-stratified cervical cancer screening
por: Wang, Jiangrong, et al.
Publicado: (2022)

Assessing Perceived Risk and STI Prevention Behavior: A National Population-Based Study with Special Reference to HPV
por: Leval, Amy, et al.
Publicado: (2011)

Type-Specific Human Papillomavirus Biological Features: Validated Model-Based Estimates
por: Baussano, Iacopo, et al.
Publicado: (2013)

Quadrivalent HPV vaccine effectiveness against high‐grade cervical lesions by age at vaccination: A population‐based study
por: Herweijer, Eva, et al.
Publicado: (2016)

Viruses in case series of tumors: Consistent presence in different cancers in the same subject
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2017)

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention
por: Dovey de la Cour, Cecilie, et al.
Publicado: (2019)

Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden
por: Pimenoff, Ville N, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nus3mnsupsdkeuceo57h5tgm61